San Diego, California
United States
60
2025-04-10
The entities that hold a legal rights for patent applications filed by inventor ICHIM THOMAS E.:
THOMAS E. ICHIM from San Diego, US has applied for patents for these inventions. The list has both pending applications and granted patents:
AUGMENTATION OF CELL THERAPY EFFICACY INCLUDING TREATMENT WITH ALPHA, 1,3 FUCOSYLTRANSFERASE
#2 | 2024-11-14METHODS AND COMPOSITIONS OF MATTER FOR TREATING CANCER AND PREDICTING RESPONSE TO THERAPY
#3 | 2024-08-15AUGMENTATION OF CELL THERAPY EFFICACY INCLUDING TREATMENT WITH ALPHA 1,3 FUCOSYLTRANSFERASE
#4 | 2023-12-28Augmentation of Cell Therapy Efficacy Including Treatment with Alpha 1,3 Fucosyltransferase
#5 | 2023-12-28ENHANCEMENT OF ALLOGRAFT QUALITY BY POSTMORTEM DONOR REGENERATION
#6 | 2020-09-24Integrative Immunotherapy for Cancer Treatment
#7 | 2020-06-04TREATMENT OF LIVER FAILURE WITH ACTIVATED T REGULATORY CELLS
#8 | 2019-09-19Generation of Tumor Endothelium Specific Viruses
#9 | 2019-08-22Augmentation of Oncolytic Viral Efficacy through Immunological Targeting Tumor Endothelial Cells
#10 | 2019-08-08Augmentation of Abscopal Effect of Cryotherapy and other Tumor Cell Death by Anti-angiogenic and Anti-tumor Vaccination
#11 | 2019-07-25Methods of Augmenting Tumor Vaccine Efficacy through Endothelial Targeting
#12 | 2019-07-04Placental Based Contraceptive Vaccine
#13 | 2019-05-30Selection of Donors for Generation of Anti-Angiogenic Vaccine Compositions Including ValloVax
#14 | 2019-01-17Augmentation of cell therapy efficacy including treatment with alpha 1,3 fucosyltransferase
#15 | 2018-10-04NANOPARTICLE BASED TUMOR ENDOTHELIAL TARGETING VACCINE
#16 | 2018-09-20Prophylactic Vaccine to Tumor Angiogenesis
#17 | 2018-09-20Immunotherapy of Aberrant Ocular Angiogenesis by Placental Vaccination
#18 | 2018-04-26Immunotherapy of Cancer by Induction of Immunologically-Mediated Selective Killing of Tumor Vasculature Using Modified Endothelial Cells and Progenitors Thereof
#19 | 2018-01-11CHIMERIC ANTIGEN RECEPTOR TARGETING OF TUMOR ENDOTHELIUM
#20 | 2017-12-07ADJUVANTS USEFUL FOR STIMULATION OF IMMUNITY TO TUMOR ENDOTHELIAL CELLS
#21 | 2017-12-07PROBIOTIC AUGMENTATION OF ANTI-TUMOR ENDOTHELIUM IMMUNE RESPONSES
#22 | 2017-10-12ENDOMETRIAL STEM CELLS AND METHODS OF MAKING AND USING SAME
#23 | 2017-08-03CLINICALLY USEFUL NON-ANTIGEN PULSED DENDRITIC CELLS
#24 | 2017-07-13POLYVALENT ANTI-TUMOR FIBROBLAST VACCINE
#25 | 2017-06-15GENE EDITED ANTIGEN PRESENTING CELLS
#26 | 2017-06-01INACTIVATION OF LYMPHOCYTE IMMUNOLOGICAL CHECKPOINTS BY GENE EDITING
#27 | 2017-06-01CHIMERIC ANTIGEN RECEPTOR DENDRITIC CELL (CAR-DC) FOR TREATMENT OF CANCER
#28 | 2017-05-25EXOSOME MEDIATED INNATE AND ADAPTIVE IMMUNE STIMULATION FOR TREATMENT OF CANCER
#29 | 2017-05-11PLACENTAL COMPOSITIONS FOR STIMULATION OF IMMUNITY TO PD-L1
#30 | 2017-04-20DNA NANOPARTICLE BASED CHECKPOINT INHIBITORS
#31 | 2017-04-13AMPLIFICATION OF EPITOPE SPECIFIC PERSONALIZED ANTI-ANGIOGENIC IMMUNE RESPONSES
#32 | 2017-04-13TREATMENT OF GLIOMA BY ANTI-ANGIOGENIC ACTIVE IMMUNIZATION FOR DIRECT TUMOR INHIBITION AND AUGMENTATION OF CHEMOTHERAPY, IMMUNOTHERAPY AND RADIOTHERAPY EFFICACY
#33 | 2017-04-06INHIBITION OF TUMOR ANGIOGENESIS BY CHECKPOINT INHIBITORS AND ACTIVE VACCINATION
#34 | 2017-02-02METHODS OF INDUCING CELL DIFFERENTIATION WITH PLACENTAL EXTRACTS
#35 | 2017-01-26AUGMENTATION OF CANCER AND CANCER ENDOTHELIAL VACCINE IMMUNOGENICITY BY HISTONE DEACETYLASE INHIBITORS
#36 | 2016-11-24BLOOD DERIVED IMMUNE STIMULATORY COMPOSITIONS
#37 | 2016-09-15STEM CELL THERAPY FOR THE TREATMENT OF AUTISM AND OTHER DISORDERS
#38 | 2016-08-18UNIVERSAL DONOR CHIMERIC ANTIGEN RECEPTOR CELLS
#39 | 2016-08-18PLACENTAL COMPOSITIONS FOR STIMULATION OF IMMUNITY TO PD-L1
#40 | 2016-08-11PROTECTION OF TCR SIGNALING CHAINS IN CANCER PATIENTS AND ENHANCEMENT OF CAR-T CELL THERAPY
#41 | 2016-08-11CHIMERIC ANTIGEN RECEPTOR TARGETING OF TUMOR ENDOTHELIUM
#42 | 2016-07-28COMPOSITE TISSUE CANCER VACCINE
#43 | 2016-07-21STIMULATION OF IMMUNITY TO ENDOTHELIAL CELLS, ENDOTHELIAL-LIKE CELLS, AND INTRATUMOR VASCULAR CHANNELS DERIVED FROM TUMOR TISSUE
#44 | 2016-01-28DEREPRESSION OF IMMUNITY IN ONCOLOGICAL AND VIROLOGICAL CONDITIONS BY HIGH MOBILITY GROUP BOX 1 DERIVED PEPTIDES
#45 | 2013-06-20Methods of inhibiting growth of a neoplastic cell
#46 | 2013-06-20ENDOMETRIAL STEM CELLS AND METHODS OF MAKING AND USING SAME
#47 | 2012-10-25ALLOGENEIC STEM CELL TRANSPLANTS IN NON-CONDITIONED RECIPIENTS
#48 | 2011-05-05COMPOSITIONS AND METHODS OF STEM CELL THERAPY FOR AUTISM
#49 | 2011-04-21AUGMENTATION OF CELL THERAPY EFFICACY INCLUDING TREATMENT WITH ALPHA 1-3 FUCOSYLTRANSFERASE
#50 | 2011-03-24METHODS OF INDUCING CELL DIFFERENTIATION WITH PLACENTAL EXTRACTS
#51 | 2010-01-14Treatment of disc degenerative disease
#52 | 2009-12-17Treatment of erectile dysfunction by stem cell therapy
#53 | 2009-11-26STEM CELL THERAPY FOR BLOOD VESSEL DEGENERATION
#54 | 2009-02-26ENDOMETRIAL STEM CELLS AND METHODS OF MAKING AND USING SAME
#55 | 2008-10-23Combination treatment of cardiovascular disease
#56 | 2008-10-16Stem Cell Therapy for the Treatment of Autism and Other Disorders
#57 | 2008-07-03Stem cell mediated treg activation/expansion for therapeutic immune modulation
#58 | 2008-02-28STEM CELL THERAPY FOR CARDIAC VALVULAR DYSFUNCTION
#59 | 2007-11-22Transcatheter tumor immunoembolization
#60 | 2007-02-22Compositions of placentally-derived stem cells for the treatment of cancer
298558 ⎘